Literature DB >> 23402099

Impact of vaccines and vaccination on global control of avian influenza.

David E Swayne1.   

Abstract

There are 30 recorded epizootics of H5 or H7 high pathogenicity avian influenza (HPAI) from 1959 to early 2012. The largest of these epizootics, affecting more birds and countries than the other 29 epizootics combined, has been the H5N1 HPAI, which began in Guangdong China in 1996, and has killed or resulted in culling of over 250 million poultry and/or wild birds in 63 countries. Most countries have used stamping-out programs in poultry to eradicate H5N1 HPAI. However, 15 affected countries have utilized vaccination as a part of the control strategy. Greater than 113 billion doses were used from 2002 to 2010. Five countries have utilized nationwide routine vaccination programs, which account for 99% of vaccine used: 1) China (90.9%), 2) Egypt (4.6%), 3) Indonesia (2.3%), 4) Vietnam (1.4%), and 5) Hong Kong Special Administrative Region (< 0.01%). Mongolia, Kazakhstan, France, The Netherlands, Cote d'Ivoire, Sudan, North Korea, Israel, Russia, and Pakistan used < 1% of the avian influenza (AI) vaccine, and the AI vaccine was targeted to either preventive or emergency vaccination programs. Inactivated AI vaccines have accounted for 95.5% of vaccine used, and live recombinant virus vaccines have accounted for 4.5% of vaccine used. The latter are primarily recombinant Newcastle disease vectored vaccine with H5 influenza gene insert. China, Indonesia, Egypt, and Vietnam implemented vaccination after H5N1 HPAI became enzootic in domestic poultry. Bangladesh and eastern India have enzootic H5N1 HPAI and have not used vaccination in their control programs. Clinical disease and mortality have been prevented in chickens, human cases have been reduced, and rural livelihoods and food security have been maintained by using vaccines during HPAI outbreaks. However, field outbreaks have occurred in vaccinating countries, primarily because of inadequate coverage in the target species, but vaccine failures have occurred following antigenic drift in field viruses within China, Egypt, Indonesia, Hong Kong, and Vietnam. The primary strategy for HPAI and H5/H7 low pathogenicity notifiable avian influenza control will continue to be immediate eradication using a four-component strategy: 1) education, 2) biosecurity, 3) rapid diagnostics and surveillance, and 4) elimination of infected poultry. Under some circumstances, vaccination can be added as an additional tool within a wider control strategy when immediate eradication is not feasible, which will maintain livelihoods and food security, and control clinical disease until a primary strategy can be developed and implemented to achieve eradication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23402099     DOI: 10.1637/10183-041012-Review.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  63 in total

1.  Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1.

Authors:  Ioannis Sitaras; Xanthoula Rousou; Donata Kalthoff; Martin Beer; Ben Peeters; Mart C M de Jong
Journal:  J R Soc Interface       Date:  2016-01       Impact factor: 4.118

Review 2.  Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.

Authors:  David E Swayne; Erica Spackman; Mary Pantin-Jackwood
Journal:  Ecohealth       Date:  2013-09-12       Impact factor: 3.184

3.  Contact between bird species of different lifespans can promote the emergence of highly pathogenic avian influenza strains.

Authors:  Paul S Wikramaratna; Oliver G Pybus; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

4.  Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.

Authors:  Ahmed Kandeil; Ahmed Mostafa; Rabeh El-Shesheny; Ahmed Nageh El-Taweel; Mokhtar Gomaa; Hussein Galal; Ghazi Kayali; Mohamed A Ali
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

5.  Culling and the Common Good: Re-evaluating Harms and Benefits under the One Health Paradigm.

Authors:  Chris Degeling; Zohar Lederman; Melanie Rock
Journal:  Public Health Ethics       Date:  2016-05-03       Impact factor: 1.940

6.  Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017.

Authors:  Jianzhong Shi; Guohua Deng; Shujie Ma; Xianying Zeng; Xin Yin; Mei Li; Bo Zhang; Pengfei Cui; Yan Chen; Huanliang Yang; Xiaopeng Wan; Liling Liu; Pucheng Chen; Yongping Jiang; Yuntao Guan; Jinxiong Liu; Wenli Gu; Shuyu Han; Yangming Song; Libin Liang; Zhiyuan Qu; Yujie Hou; Xiurong Wang; Hongmei Bao; Guobin Tian; Yanbing Li; Li Jiang; Chengjun Li; Hualan Chen
Journal:  Cell Host Microbe       Date:  2018-09-27       Impact factor: 21.023

7.  Laboratory diagnosis of avian influenza virus H7N9 infection in a renal transplant recipient.

Authors:  Jun Cheng; Bo Wang; Xiaoxiao Jiang; Dawei Cui; Jian Chen; Yuzhu Dai; Changgui Sun
Journal:  Int J Clin Exp Med       Date:  2014-02-15

Review 8.  Avian influenza viruses in humans: lessons from past outbreaks.

Authors:  Yao-Tsun Li; Martin Linster; Ian H Mendenhall; Yvonne C F Su; Gavin J D Smith
Journal:  Br Med Bull       Date:  2019-12-11       Impact factor: 4.291

9.  Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.

Authors:  Ahmed Kandeil; Ahmed Kayed; Yassmin Moatasim; Richard J Webby; Pamela P McKenzie; Ghazi Kayali; Mohamed A Ali
Journal:  J Gen Virol       Date:  2017-07-19       Impact factor: 3.891

10.  Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens.

Authors:  Yinghua Tang; Jihu Lu; Peipei Wu; Zhenxing Liu; Zhen Tian; Guofei Zha; Hui Chen; Qiaochu Wang; Qiaoxiu Wang; Fengxiang Hou; Sang-Moo Kang; Jibo Hou
Journal:  Vet Microbiol       Date:  2014-05-13       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.